Summary of prognostic features in cutaneous LBCLs
Parameter . | 5-y disease-specific survival, % . | 10-y disease-specific survival, % . | P . |
|---|---|---|---|
| Round cells predominate (LBCLLT+LBCLO) | 58.2 | 0 | — |
| Cleaved cells predominate (FCLDT) | 86.7 | 86.7 | .02 |
| Age older than 70 y | 61.4 | 46.0 | — |
| Age 70 y or younger | 88.7 | 88.7 | .007 |
| Site: leg | 52.6 | 0 | — |
| Site: not leg or multiple | 84.9 | 84.9 | .001 |
| No. of lesions | |||
| 1 | 72.3 | 72.3 | — |
| 2 | 75.8 | 68.2 | 1 |
| Bcl-2+ | 66.6 | 44.4 | — |
| Bcl-2− | 84.6 | 84.6 | .05 |
| FOX-P1+ | 57.9 | 43.4 | — |
| FOX-P1− | 85.9 | 85.9 | .03 |
| MUM-1+ | 52.4 | 52.4 | — |
| MUM-1− | 84.8 | 77.8 | .05 |
| CD10 and/or Bcl-6 positive | 77.9 | 70.8 | — |
| CD10 and Bcl-6 both negative | 57.8 | 57.8 | .2 |
Parameter . | 5-y disease-specific survival, % . | 10-y disease-specific survival, % . | P . |
|---|---|---|---|
| Round cells predominate (LBCLLT+LBCLO) | 58.2 | 0 | — |
| Cleaved cells predominate (FCLDT) | 86.7 | 86.7 | .02 |
| Age older than 70 y | 61.4 | 46.0 | — |
| Age 70 y or younger | 88.7 | 88.7 | .007 |
| Site: leg | 52.6 | 0 | — |
| Site: not leg or multiple | 84.9 | 84.9 | .001 |
| No. of lesions | |||
| 1 | 72.3 | 72.3 | — |
| 2 | 75.8 | 68.2 | 1 |
| Bcl-2+ | 66.6 | 44.4 | — |
| Bcl-2− | 84.6 | 84.6 | .05 |
| FOX-P1+ | 57.9 | 43.4 | — |
| FOX-P1− | 85.9 | 85.9 | .03 |
| MUM-1+ | 52.4 | 52.4 | — |
| MUM-1− | 84.8 | 77.8 | .05 |
| CD10 and/or Bcl-6 positive | 77.9 | 70.8 | — |
| CD10 and Bcl-6 both negative | 57.8 | 57.8 | .2 |
— indicates not applicable.